Dr. Iain Stuart
Chief Scientific Officer
Iain Stuart, PhD, has served as our Chief Scientific Officer since March 2020. Previously, Dr. Stuart was with Foamix Pharmaceuticals Ltd. joining in October 2016, where he served as Senior Vice President of Research and Development until January of 2019 when he took on the role of Chief Scientific Officer. He has over 19 years of industry experience, previously holding various positions at LEO Pharma, Inc. from 2008 to 2016, including Director of Preclinical Development, Director of Clinical Operations, Vice President of Research and Development Project Management, and, most recently, as Vice President of Medical Strategy and Scientific Affairs. Prior to LEO Pharma, Dr. Stuart served as Senior Study Director at Inveresk Research (now Charles River), and as Project Manager, Pharmaceutical Development at Cyclacel, Inc. Dr. Stuart has a PhD and first-class honors BSc in chemistry from Glasgow Caledonian University, and was a postdoctoral fellow in medicinal chemistry at the University of Strathclyde.